New Zealand markets closed

Phio Pharmaceuticals Corp (44R3.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.46980.0000 (0.00%)
At close: 09:17AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
5,346
6,332
7,012
8,886
3,716
-
Selling general and administrative
3,959
4,366
4,450
4,625
5,077
-
Total operating expenses
9,305
10,698
11,462
13,511
8,793
-
Operating income or loss
-9,305
-10,698
-11,462
-13,511
-8,793
-
Total other income/expenses net
-
-128
-18
224
-1
-
Income before tax
-9,378
-10,826
-11,480
-13,287
-8,794
-
Income tax expense
-
-
0
0
0
0
Income from continuing operations
-9,378
-10,826
-11,480
-13,287
-8,794
-
Net income
-9,378
-10,826
-11,480
-13,287
-8,794
-
Net income available to common shareholders
-9,378
-10,826
-11,480
-13,287
-8,794
-
Basic EPS
-7.43
-5.20
-10.10
-12.43
-23.04
-
Diluted EPS
-7.43
-5.20
-10.10
-12.43
-23.04
-
Basic average shares
1,616
2,084
1,137
1,070
382.278
-
Diluted average shares
1,616
2,084
1,137
1,070
382.278
-